Beyond Air (XAIR) Stock: Buy, Sell, or Hold?
XAIR - Beyond Air, Inc. Common Stock
$2.59
-0.26 (-9.12%)
▼
5d:
-17.25%
30d:
-54.56%
90d:
+457.47%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When XAIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XAIR is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: XAIR is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: XAIR is currently trading at $2.59, which is considered oversold relative to its 30-day fair value range of $2.83 to $4.46.
Technical Outlook: Technically, XAIR is in a strong uptrend. Immediate support is located at $2.38, while resistance sits at $3.26. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: XAIR scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+672.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XAIR is in a strong uptrend. Immediate support is located at $2.38, while resistance sits at $3.26. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: XAIR scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+672.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.83 -
$4.46
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.1%)
- BULLISH: Trading 672.2% below Wall St target ($20.00)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.83 -
$4.46
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.38
Resistance Level
$3.26
Current Trend
Strong Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.46
Wall Street Target
$20.00
(+672.2%)
Revenue Growth (YoY)
0.5%
Share & Embed Analysis
Last updated: September 29, 2026 7:45 AM ET
Data refreshes hourly during market hours. Next update: 8:45 AM
Data refreshes hourly during market hours. Next update: 8:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XAIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 54 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 68 BUY |
